Journal of Health Economics and Outcomes Research
@journalheor.bsky.social
An international high-quality, open-access journal covering all fields and methodologies related to health economics and outcomes research. Indexed in PubMed, PubMed Central (PMC), Web of Science Emerging Sources Citation Index, DOAJ, Google Scholar.
Post-Dobbs abortion bans disproportionately associated with increased PPD risk among individuals in low-SES communities, amplifying existing health disparities. #postpartum #depression #Dobbs #abortion
SES and Postpartum Depression Risk by State Trigger Laws After Dobbs
This cohort study analyzes associations of state-level abortion bans enacted after the Dobbs v Jackson Women’s Health Organization decision with incidence of postpartum depression among individuals wi...
jamanetwork.com
February 3, 2026 at 10:39 PM
Post-Dobbs abortion bans disproportionately associated with increased PPD risk among individuals in low-SES communities, amplifying existing health disparities. #postpartum #depression #Dobbs #abortion
Reposted by Journal of Health Economics and Outcomes Research
Large share of older US adults haven’t had a recent flu or COVID vaccine, poll finds
Of adults ages 50 and older, 42% remain unvaccinated.
www.cidrap.umn.edu/c...
Of adults ages 50 and older, 42% remain unvaccinated.
www.cidrap.umn.edu/c...
February 3, 2026 at 10:23 PM
Large share of older US adults haven’t had a recent flu or COVID vaccine, poll finds
Of adults ages 50 and older, 42% remain unvaccinated.
www.cidrap.umn.edu/c...
Of adults ages 50 and older, 42% remain unvaccinated.
www.cidrap.umn.edu/c...
Reposted by Journal of Health Economics and Outcomes Research
I am hearing that RFK Jr.’s minions are going to go after HPV vaccines. I’ve got problems with these people and now you’re going to hear about them, first from a personal perspective and then from a professional one.
It all boils down to this: WE HAVE A SAFE VACCINE THAT PREVENTS CANCER.
It all boils down to this: WE HAVE A SAFE VACCINE THAT PREVENTS CANCER.
January 28, 2026 at 7:52 PM
I am hearing that RFK Jr.’s minions are going to go after HPV vaccines. I’ve got problems with these people and now you’re going to hear about them, first from a personal perspective and then from a professional one.
It all boils down to this: WE HAVE A SAFE VACCINE THAT PREVENTS CANCER.
It all boils down to this: WE HAVE A SAFE VACCINE THAT PREVENTS CANCER.
Reposted by Journal of Health Economics and Outcomes Research
Universal self-collection of cervical samples may hike #HPV screening rates
Offering self-collection to all women can improve health equity and speed the global elimination of cervical cancer, the authors say.
www.cidrap.umn.edu/h...
Offering self-collection to all women can improve health equity and speed the global elimination of cervical cancer, the authors say.
www.cidrap.umn.edu/h...
January 28, 2026 at 8:19 PM
Universal self-collection of cervical samples may hike #HPV screening rates
Offering self-collection to all women can improve health equity and speed the global elimination of cervical cancer, the authors say.
www.cidrap.umn.edu/h...
Offering self-collection to all women can improve health equity and speed the global elimination of cervical cancer, the authors say.
www.cidrap.umn.edu/h...
New study in JHEOR assesses the cost-effectiveness of the TYRX antibacterial envelope in preventing cardiac implantable electronic device infections in Spain, showing it is cost-effective or cost-saving across device types. #HEOR #InfectionControl #Spain #MedicalDevices jheor.org/article/154974
January 26, 2026 at 3:33 PM
New study in JHEOR assesses the cost-effectiveness of the TYRX antibacterial envelope in preventing cardiac implantable electronic device infections in Spain, showing it is cost-effective or cost-saving across device types. #HEOR #InfectionControl #Spain #MedicalDevices jheor.org/article/154974
New study evaluating real-world Medicare data shows reduced healthcare utilization after pimavanserin initiation in newly diagnosed, treatment-naïve Parkinson’s disease psychosis patients. jheor.org/article/154805 #Parkinsons #pimavanserin #HEOR
January 23, 2026 at 5:47 PM
New study evaluating real-world Medicare data shows reduced healthcare utilization after pimavanserin initiation in newly diagnosed, treatment-naïve Parkinson’s disease psychosis patients. jheor.org/article/154805 #Parkinsons #pimavanserin #HEOR
Reposted by Journal of Health Economics and Outcomes Research
Remember that exploitative and unethical clinical trial of HepB vaccine in Guinea-Bissau that RFK Jr. funded?
It’s been cancelled.
It’s been cancelled.
Controversial US study on hepatitis B vaccines in Africa is cancelled
$1.6m project drew outrage over ethical questions about withholding vaccines proven to prevent disease
www.theguardian.com
January 15, 2026 at 5:53 PM
Remember that exploitative and unethical clinical trial of HepB vaccine in Guinea-Bissau that RFK Jr. funded?
It’s been cancelled.
It’s been cancelled.
Reposted by Journal of Health Economics and Outcomes Research
📊 This new interactive from USC Schaeffer lets researchers and policymakers explore how medical spending for Medicare beneficiaries with #dementia has changed across time, states, demographics and care settings.
Explore the data here ⤵️
Explore the data here ⤵️
How Medical Costs for People with Dementia Are Changing Over Time and Across the U.S. - January 15, 2026 - USC Schaeffer
Explore medical spending for Medicare beneficiaries with dementia in this interactive from the U.S. Cost of Dementia project. - January 15, 2026
schaeffer.usc.edu
January 15, 2026 at 6:44 PM
📊 This new interactive from USC Schaeffer lets researchers and policymakers explore how medical spending for Medicare beneficiaries with #dementia has changed across time, states, demographics and care settings.
Explore the data here ⤵️
Explore the data here ⤵️
As the EPA reportedly plans to move away from putting dollar figures on the costs of premature deaths toward industry costs, the economist who developed those metrics weighs in.
Q&A with economist W. Kip Viscusi
As a major federal agency reportedly moves away from monetizing the health benefits of regulations, the economist who developed those metrics weighs in.
journalistsresource.org
January 15, 2026 at 7:40 PM
As the EPA reportedly plans to move away from putting dollar figures on the costs of premature deaths toward industry costs, the economist who developed those metrics weighs in.
Reposted by Journal of Health Economics and Outcomes Research
Hospitals prep for rising ER visits as ACA subsidy lapse leaves patients with ‘impossible choices’ www.beckershospitalreview.com/finance/hosp...
www.beckershospitalreview.com
January 14, 2026 at 3:58 PM
Hospitals prep for rising ER visits as ACA subsidy lapse leaves patients with ‘impossible choices’ www.beckershospitalreview.com/finance/hosp...
Reposted by Journal of Health Economics and Outcomes Research
Last night with no warning, RFK Jr. cancelled up to $2 billion in funding for mental health and substance abuse research and programs administered through SAMHSA.
He and his minions did so because “they no longer believe the defunded programs align with the Trump administration's priorities”.
He and his minions did so because “they no longer believe the defunded programs align with the Trump administration's priorities”.
Trump administration sends letter wiping out addiction, mental health grants
The Trump administration sent hundreds of letters Tuesday terminating federal grants supporting mental health and drug addiction services.
www.npr.org
January 14, 2026 at 3:37 PM
Last night with no warning, RFK Jr. cancelled up to $2 billion in funding for mental health and substance abuse research and programs administered through SAMHSA.
He and his minions did so because “they no longer believe the defunded programs align with the Trump administration's priorities”.
He and his minions did so because “they no longer believe the defunded programs align with the Trump administration's priorities”.
Reposted by Journal of Health Economics and Outcomes Research
That we're in a place, at a time, when someone has to write this headline, this article — it's almost unfathomable. Please do read @krutikakuppalli.bsky.social's take. www.statnews.com/2026/01/12/m...
Medical schools must prepare tomorrow’s doctors for yesterday’s diseases
Medical schools must now prepare tomorrow’s doctors for yesterday’s diseases.
www.statnews.com
January 12, 2026 at 4:46 PM
That we're in a place, at a time, when someone has to write this headline, this article — it's almost unfathomable. Please do read @krutikakuppalli.bsky.social's take. www.statnews.com/2026/01/12/m...
Reposted by Journal of Health Economics and Outcomes Research
States, health organizations reject new CDC vaccine guidance
A growing number of states are pushing back against sweeping changes to the US childhood vaccine schedule.
www.cidrap.umn.edu/p...
A growing number of states are pushing back against sweeping changes to the US childhood vaccine schedule.
www.cidrap.umn.edu/p...
January 12, 2026 at 5:36 PM
States, health organizations reject new CDC vaccine guidance
A growing number of states are pushing back against sweeping changes to the US childhood vaccine schedule.
www.cidrap.umn.edu/p...
A growing number of states are pushing back against sweeping changes to the US childhood vaccine schedule.
www.cidrap.umn.edu/p...
Reposted by Journal of Health Economics and Outcomes Research
Maternal #flu, #Tdap vaccination cuts risk of infant hospitalization, ED visits 70% to 89%, researchers estimate
But vaccine uptake was suboptimal, particularly for the flu vaccine.
www.cidrap.umn.edu/d...
But vaccine uptake was suboptimal, particularly for the flu vaccine.
www.cidrap.umn.edu/d...
January 9, 2026 at 6:49 PM
Maternal #flu, #Tdap vaccination cuts risk of infant hospitalization, ED visits 70% to 89%, researchers estimate
But vaccine uptake was suboptimal, particularly for the flu vaccine.
www.cidrap.umn.edu/d...
But vaccine uptake was suboptimal, particularly for the flu vaccine.
www.cidrap.umn.edu/d...
Reposted by Journal of Health Economics and Outcomes Research
New from @helenbranswell.bsky.social with a chart by me: the United States is now a global outlier when it comes to vaccines
www.statnews.com/2026/01/09/c...
www.statnews.com/2026/01/09/c...
January 9, 2026 at 2:38 PM
New from @helenbranswell.bsky.social with a chart by me: the United States is now a global outlier when it comes to vaccines
www.statnews.com/2026/01/09/c...
www.statnews.com/2026/01/09/c...
Reposted by Journal of Health Economics and Outcomes Research
Infectious disease experts are dismayed that the monoclonal antibody against respiratory syncytial virus (RSV) for infants, widely considered a crucial advance in public health, has been downgraded on the childhood immunization schedule.
https://www.medpagetoday.com/pediatrics/rsv/119322?trw=no
https://www.medpagetoday.com/pediatrics/rsv/119322?trw=no
Will Progress on Protecting Young Kids From RSV Be Reversed?
Kennedy's vax changes come as new products were making a dent in RSV hospitalizations
www.medpagetoday.com
January 8, 2026 at 4:22 PM
Infectious disease experts are dismayed that the monoclonal antibody against respiratory syncytial virus (RSV) for infants, widely considered a crucial advance in public health, has been downgraded on the childhood immunization schedule.
https://www.medpagetoday.com/pediatrics/rsv/119322?trw=no
https://www.medpagetoday.com/pediatrics/rsv/119322?trw=no
Reposted by Journal of Health Economics and Outcomes Research
Questions about vaccine safety or ingredients may emerge during routine pediatric visits.
Clinicians can address these concerns by explaining vaccine safety monitoring and proactively offering reliable information.
ja.ma/3NzRSri
Clinicians can address these concerns by explaining vaccine safety monitoring and proactively offering reliable information.
ja.ma/3NzRSri
January 7, 2026 at 3:45 PM
Questions about vaccine safety or ingredients may emerge during routine pediatric visits.
Clinicians can address these concerns by explaining vaccine safety monitoring and proactively offering reliable information.
ja.ma/3NzRSri
Clinicians can address these concerns by explaining vaccine safety monitoring and proactively offering reliable information.
ja.ma/3NzRSri
Reposted by Journal of Health Economics and Outcomes Research
COVID19 data from a new paper:
October 2022-September 2023
-43.6 million cases
-10.0 million outpatient visits
-1.1 million hospitalizations, and -101,300 deaths
October 2023-September 2024
-33.0 million cases
-7.7 million outpatient visits, -879,100 hospitalizations, and -100,800 deaths.
October 2022-September 2023
-43.6 million cases
-10.0 million outpatient visits
-1.1 million hospitalizations, and -101,300 deaths
October 2023-September 2024
-33.0 million cases
-7.7 million outpatient visits, -879,100 hospitalizations, and -100,800 deaths.
Estimated Burden of COVID-19 Illnesses, Medical Visits, Hospitalizations, and Deaths
This cross-sectional study estimates the age group-specific burden of COVID-19–associated illnesses, outpatient visits, hospitalizations, and deaths in the US from October 2022 to September 2024.
jamanetwork.com
January 7, 2026 at 12:29 AM
COVID19 data from a new paper:
October 2022-September 2023
-43.6 million cases
-10.0 million outpatient visits
-1.1 million hospitalizations, and -101,300 deaths
October 2023-September 2024
-33.0 million cases
-7.7 million outpatient visits, -879,100 hospitalizations, and -100,800 deaths.
October 2022-September 2023
-43.6 million cases
-10.0 million outpatient visits
-1.1 million hospitalizations, and -101,300 deaths
October 2023-September 2024
-33.0 million cases
-7.7 million outpatient visits, -879,100 hospitalizations, and -100,800 deaths.
Reposted by Journal of Health Economics and Outcomes Research
A Study Is Retracted, Renewing Concerns About the Weedkiller Roundup www.nytimes.com/2026/01/02/c...
A Study Is Retracted, Renewing Concerns About the Weedkiller Roundup
www.nytimes.com
January 2, 2026 at 6:48 PM
A Study Is Retracted, Renewing Concerns About the Weedkiller Roundup www.nytimes.com/2026/01/02/c...
Reposted by Journal of Health Economics and Outcomes Research
In April, medical journals received letters from DOJ probing whether they are "partisans in various scientific debates."
But since then, the publications haven't heard anything from DOJ, several of the journals confirmed.
https://www.medpagetoday.com/washington-watch/washington-watch/119233?trw=no
But since then, the publications haven't heard anything from DOJ, several of the journals confirmed.
https://www.medpagetoday.com/washington-watch/washington-watch/119233?trw=no
DOJ Sent Letters to Medical Journals. Then What Happened?
Worrying probe into publications' partisanship may have lost steam
www.medpagetoday.com
January 2, 2026 at 7:11 PM
In April, medical journals received letters from DOJ probing whether they are "partisans in various scientific debates."
But since then, the publications haven't heard anything from DOJ, several of the journals confirmed.
https://www.medpagetoday.com/washington-watch/washington-watch/119233?trw=no
But since then, the publications haven't heard anything from DOJ, several of the journals confirmed.
https://www.medpagetoday.com/washington-watch/washington-watch/119233?trw=no
In a study using real-world data, Black patients with #mCSPC treated with #apalutamide achieved earlier and higher deep PSA responses than those receiving #abiraterone acetate, suggesting improved outcomes in an understudied population. jheor.org/article/151273 #HEOR #prostatecancer
December 30, 2025 at 2:22 PM
In a study using real-world data, Black patients with #mCSPC treated with #apalutamide achieved earlier and higher deep PSA responses than those receiving #abiraterone acetate, suggesting improved outcomes in an understudied population. jheor.org/article/151273 #HEOR #prostatecancer
JHEOR extends its deepest appreciation to the peer reviewers who invested their time and expertise into providing feedback on the scores of manuscripts we received in 2025. #peerreview #HEOR
Interested in reviewing? Learn more at jheor.org/pages/157-fo...
Interested in reviewing? Learn more at jheor.org/pages/157-fo...
December 29, 2025 at 4:08 PM
JHEOR extends its deepest appreciation to the peer reviewers who invested their time and expertise into providing feedback on the scores of manuscripts we received in 2025. #peerreview #HEOR
Interested in reviewing? Learn more at jheor.org/pages/157-fo...
Interested in reviewing? Learn more at jheor.org/pages/157-fo...
New study highlights first national estimate of the economic burden of #RSV infection in #Colombia, highlighting high costs in infants and older adults and supporting targeted prevention and policy planning. #HEOR #prevention #economics
December 19, 2025 at 4:32 PM
New study highlights first national estimate of the economic burden of #RSV infection in #Colombia, highlighting high costs in infants and older adults and supporting targeted prevention and policy planning. #HEOR #prevention #economics
New study estimates the substantial economic burden of #alopecia areata in Saudi Arabia, showing high societal costs driven mainly by productivity loss, especially in severe and refractory disease. #HEOR jheor.org/article/151864
December 19, 2025 at 3:02 PM
New study estimates the substantial economic burden of #alopecia areata in Saudi Arabia, showing high societal costs driven mainly by productivity loss, especially in severe and refractory disease. #HEOR jheor.org/article/151864
In a real-world study of Black patients with metastatic prostate cancer, #apalutamide produced earlier and deeper PSA responses than #abiraterone acetate, highlighting potential clinical benefits in an understudied population. jheor.org/article/146844 #HEOR #ProstateCancer #BlackPatients
December 16, 2025 at 7:40 PM
In a real-world study of Black patients with metastatic prostate cancer, #apalutamide produced earlier and deeper PSA responses than #abiraterone acetate, highlighting potential clinical benefits in an understudied population. jheor.org/article/146844 #HEOR #ProstateCancer #BlackPatients